LKE are a 1.2 billion MC (99c)
CXO are a 1.3 billion MC
CXO are a soon to be lithium producer where as LKE are quite a way behind.
Yes LKE have their own patent but with that Carries a degree of risk and obviously they are far behind CXO in terms of production.
CXO have direct shipping ports to Asia etc.
IMO CXOs MC should be a lot higher than LKEs as CXO will be one of the next Lithium producers with massive land mass and proven resource/grade/versatility.
LKE have 5 brokers that rate LKE as a “Strong buy”.
imo, and to a degree, CXO is still flying under the radar!
CXO will continue to steadily rise as it has done for the last year and once news of production starts, $2 will be cheap I feel.
All my opinion but the graphs and fundamentals can tell the story here. CXO still has a very long way to go.
Look at the volume/money exchanged today on a solid green day and the market agrees without a doubt.
I’m no broker, but CXO is still a STRONG buy for me (I averaged up today)
GLA.
- Forums
- ASX - By Stock
- CXO
- Banter and general comments
Banter and general comments, page-6741
-
- There are more pages in this discussion • 32,255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $256.4M |
Open | High | Low | Value | Volume |
11.5¢ | 12.5¢ | 11.0¢ | $3.037M | 25.36M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 318278 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 2878347 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 318278 | 0.120 |
40 | 2995146 | 0.115 |
60 | 4820343 | 0.110 |
43 | 4085339 | 0.105 |
85 | 4725746 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 2878347 | 41 |
0.130 | 1714806 | 38 |
0.135 | 1280459 | 21 |
0.140 | 837938 | 9 |
0.145 | 762740 | 16 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online